Our Company

Our parent company Merck Serono, headquartered in Geneva, Switzerland, is the division of Merck KGaA for innovative small molecules and biopharmaceuticals. In Canada, the division operates as EMD Serono, Canada.

EMD Serono, Canada, employs roughly 150 people across many disciplines including sales and marketing, medical and regulatory affairs, drug safety, quality assurance, market access, compliance, and patient services. Integral to the continued growth of EMD Serono, Canada, is our active search for opportunities to partner with biotechnology and pharmaceutical companies, as well as leading academic institutions.

EMD Serono, Canada, has been an advocate for research and access to applied technology in the biotechnology arena for over ten years through our membership in BIOTECanada. In addition, EMD Serono, Canada, is a proud member of Rx&D, Canada’s association of research-based pharmaceutical companies.

Merck Serono has a strong world-wide presence and demonstrates comprehensive skills in all areas from research to development to production and sales. Merck Serono is committed to bringing therapeutic innovations to patients. Around the world, some 16,000 employees work to discover, develop, manufacture and commercialize Merck Serono’s prescription therapies, available in over 150 countries.

Merck Serono is a world-leader in biotechnological innovation. We combine state-of-the-art R&D with a global manufacturing capability, integrated and focused on our goal of meeting the needs of patients and physicians in our chosen therapy areas. As a leader in the development of recombinant (genetically engineered) protein therapeutics and small molecules, we are committed to leveraging the opportunities presented by biotechnology to improve people’s quality of life.